LHX Form 4: Kubasik Exercises Options and Sells 40,138 Shares

Rhea-AI Filing Summary

Christopher E. Kubasik, Chair and CEO and a director of L3Harris Technologies (LHX), reported transactions dated 08/11/2025 involving company common stock. The filing shows a sale of 40,138 shares with weighted average sale prices reported in a range of $267.99 to $270.63. The report also discloses a non-qualified stock option position with an exercise price of $149.31 covering 40,138 shares (exercisable 06/29/2019, expiring 12/20/2027). The filing notes 30,000 shares held indirectly by a grantor retained annuity trust. All transactions were reported on a Form 4 signed by an attorney-in-fact.

Positive

• Timely insider disclosure by the Chair and CEO on Form 4, fulfilling Section 16 reporting requirements
• Option details disclosed: non-qualified option exercise price of $149.31 covering 40,138 shares with exercisable and expiration dates

Negative

• Reported disposition of 40,138 shares on 08/11/2025 with weighted average sale prices ranging $267.99–$270.63
• Form provides no explanatory detail within the filing about the reason for the sale or any associated trading plan

Insights

Financial Analyst

TL;DR: CEO reported exercise of options and a contemporaneous sale of 40,138 shares at roughly $268–$271 per share.

The filing documents an option-related position with an exercise price of $149.31 for 40,138 shares alongside a reported disposition of the same number of shares on 08/11/2025. The disclosed sale prices ranged from $267.99 to $270.63, suggesting the transactions involved material cash proceeds relative to a single-day insider sale. The presence of exercised options and an associated sale is consistent with common executive liquidity events and option-exercise activity, but the filing contains no commentary on the purpose of the sale or any 10b5-1 plan designation.

Corporate Governance Expert

TL;DR: Insider disclosure is complete and timely; transactions include option-related activity and indirect holdings in a trust.

The Form 4 identifies Christopher Kubasik as both an officer (Chair and CEO) and director, and reports indirect ownership of 30,000 shares in a grantor retained annuity trust. The filing appears to disclose the material elements required under Section 16, including exercise price, exercisable and expiration dates for the non-qualified option. The form does not provide any additional governance context such as whether the sale was pre-planned or required by diversification needs, so governance implications must be judged on this factual disclosure alone.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KUBASIK CHRISTOPHER E

(Last) (First) (Middle)

C/O L3HARRIS TECHNOLOGIES, INC.

1025 W. NASA BOULEVARD

(Street)

MELBOURNE FL 32919

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
L3HARRIS TECHNOLOGIES, INC. /DE/ [ LHX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chair and CEO

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, Par Value $1.00	08/11/2025		M		40,138	A	$149.31	185,715.82	D
Common Stock, Par Value $1.00	08/11/2025		S		40,138	D	$269.52(1)	145,577.82	D
Common Stock, Par Value $1.00								30,000	I	By grantor retained annuity trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (Right to Buy)	$149.31	08/11/2025		M			40,138	06/29/2019	12/20/2027	Common Stock, Par Value $1.00	40,138	$0	0	D

Explanation of Responses:

1. Reflects the weighted average sale price (prices actually received ranged from $267.99 to $270.63). The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Remarks:

	By: /s/ John C. Scarborough, Jr., Attorney-in-Fact For: Christopher E. Kubasik	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Christopher E. Kubasik report on the Form 4 for LHX?

The Form 4 reports option-related activity and a sale: a non-qualified stock option with an $149.31 exercise price covering 40,138 shares, and a reported sale of 40,138 shares on 08/11/2025.

How many shares were sold and at what prices in the LHX Form 4?

40,138 shares were reported sold with weighted average sale prices ranging from $267.99 to $270.63.

Does the filing show any indirect holdings for the reporting person?

Yes. The filing discloses 30,000 shares held indirectly by a grantor retained annuity trust.

What are the exercisable and expiration dates for the reported options?

The non-qualified stock option covering 40,138 shares is shown as exercisable on 06/29/2019 and expiring on 12/20/2027.

Was the Form 4 signed directly by the reporting person?

The Form 4 was signed by an attorney-in-fact on behalf of Christopher E. Kubasik, as indicated in the filing.